Zydus Lifesciences Jumps 4% on Apollo Cancer Test Tie-Up

Zydus Lifesciences hit a fresh 52 week high of Rs 1,142.90 on Friday, 3 July, after tying up with Apollo for a cancer test.

The trigger was Zydus signing an agreement to bring a new cancer screening test to India through Apollo’s hospital network.

Here’s what the deal actually involves. Zydus has signed a Memorandum of Understanding with Apollo Hospitals to offer the Shield Multi-Cancer Detection test across India.

This isn’t a test Zydus built from scratch though. The company already holds exclusive rights to sell it in India through an earlier agreement with Guardant Health, the US firm that developed the technology.

Friday’s deal is about expanding where and how patients can actually access it, with Apollo now offering the test through its diagnostic centres.

In simple terms, the test needs just one blood sample to check for signs of 10 common cancers at once, including breast, lung, liver and pancreatic cancer.

It’s designed for people aged 45 and above who don’t have symptoms but fall in the average risk category.

It has received a Breakthrough Device Designation from the US drug regulator, which speeds up review but doesn’t count as full approval.

Doctors have also flagged that a positive result only means further tests are needed, it isn’t a diagnosis on its own.

For Zydus, this adds another piece to its diagnostics and consumer health push, alongside its core pharmaceutical business. The company has not disclosed pricing for the test in India yet.

Zydus Lifesciences shares closed Friday’s session at Rs 1,142.90 on the NSE, up 3.92% from the previous close of Rs 1,099.80.

The stock has been on a strong run this year, up close to 25% since January and up nearly 4% in just the past week.

Unlock profitable opportunities every day! Tradz by EquityPandit provides actionable intraday trading signals for stocks and futures. Don’t miss out – download Tradz by EquityPandit and start winning now!

The post Zydus Lifesciences Jumps 4% on Apollo Cancer Test Tie-Up appeared first on Equitypandit.